| Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview S Kumar, M Saradhi, NK Chaturvedi, RK Tyagi Molecular and cellular endocrinology 246 (1-2), 147-156, 2006 | 130 | 2006 |
| Human prostatic acid phosphatase: structure, function and regulation S Muniyan, NK Chaturvedi, JG Dwyer, CA LaGrange, WG Chaney, MF Lin International journal of molecular sciences 14 (5), 10438-10464, 2013 | 96 | 2013 |
| Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease AK Mittal, NK Chaturvedi, KJ Rai, CE Gilling-Cutucache, TM Nordgren, ... Molecular medicine 20, 290-301, 2014 | 83 | 2014 |
| Lymph node‐induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin‐1 CE Gilling, AK Mittal, NK Chaturvedi, J Iqbal, P Aoun, PJ Bierman, ... British journal of haematology 158 (2), 216-231, 2012 | 70 | 2012 |
| Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia AK Mittal, NK Chaturvedi, RA Rohlfsen, P Gupta, AD Joshi, GV Hegde, ... PloS one 8 (8), e70352, 2013 | 57 | 2013 |
| Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders NK Chaturvedi, S Kumar, S Negi, RK Tyagi Molecular and cellular biochemistry 345, 291-308, 2010 | 47 | 2010 |
| Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy NK Chaturvedi, MJ Kling, DW Coulter, TR McGuire, S Ray, V Kesherwani, ... Oncotarget 9 (24), 16619, 2018 | 41 | 2018 |
| Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells YW Chou, NK Chaturvedi, S Ouyang, FF Lin, D Kaushik, J Wang, I Kim, ... Cancer letters 311 (2), 177-186, 2011 | 41 | 2011 |
| Novel Treatment for Mantle Cell Lymphoma including Therapy-resistant Tumor by NF-κB and mTOR Dual Targeting Approach JSSMCTA Chaturvedi NK, Rajule RN, Shukla A, Radhakrishnan Molecular Cancer Therapeutics, 2013 | 29 | 2013 |
| Shuttling components of nuclear import machinery involved in nuclear translocation of steroid receptors exit nucleus via exportin-1/CRM-1* independent pathway S Kumar, NK Chaturvedi, M Nishi, M Kawata, RK Tyagi Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1691 (2-3), 73-77, 2004 | 29 | 2004 |
| Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL A Shukla, K Rai, V Shukla, NK Chaturvedi, RG Bociek, SJ Pirruccello, ... Blood, The Journal of the American Society of Hematology 127 (19), 2310-2321, 2016 | 28 | 2016 |
| Agonist-mediated docking of androgen receptor onto the mitotic chromatin platform discriminates intrinsic mode of action of prostate cancer drugs S Kumar, NK Chaturvedi, S Kumar, RK Tyagi Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1783 (1), 59-73, 2008 | 28 | 2008 |
| Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma NK Chaturvedi, S Mahapatra, V Kesherwani, MJ Kling, M Shukla, S Ray, ... BMC cancer 19, 1-11, 2019 | 25 | 2019 |
| Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecan JSS Chaturvedi NK, McGuire TR, Coulter DW, Shukla A, McIntyre EM, Sharp JG Oncotarget, 2016 | 24 | 2016 |
| Subgroup-specific diagnostic, prognostic, and predictive markers influencing pediatric medulloblastoma treatment S Ray, NK Chaturvedi, KK Bhakat, A Rizzino, S Mahapatra Diagnostics 12 (1), 61, 2021 | 23 | 2021 |
| miR-15a and miR-15b modulate natural killer and CD8+ T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma AS Pathania, P Prathipati, OA Olwenyi, S Chava, OV Smith, SC Gupta, ... Molecular Therapy-Oncolytics 25, 308-329, 2022 | 21 | 2022 |
| Long non-coding RNA profiling of pediatric Medulloblastoma V Kesherwani, M Shukla, DW Coulter, JG Sharp, SS Joshi, NK Chaturvedi BMC Medical Genomics 13, 1-14, 2020 | 20 | 2020 |
| Suppression of STAT3 NH2‐terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de‐repression by … S Ray, DW Coulter, SD Gray, JA Sughroue, S Roychoudhury, ... Molecular carcinogenesis 57 (4), 536-548, 2018 | 19 | 2018 |
| Amino acids regulate cisplatin insensitivity in neuroblastoma V Gunda, AS Pathania, S Chava, P Prathipati, NK Chaturvedi, DW Coulter, ... Cancers 12 (9), 2576, 2020 | 17 | 2020 |
| Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy H Song, R Bhakat, MJ Kling, DW Coulter, NK Chaturvedi, S Ray, SS Joshi Biochemical and biophysical research communications 520 (2), 250-256, 2019 | 17 | 2019 |
